Latest News

KDM1 may represent a new therapeutic target for glioma

Researchers have generated preclinical data demonstrating that the protein KDM1, which functions as a lysine demethylase, is a potential target for glioma treatment, according to new research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Major vascular anomalies found in brains of people with Huntington's disease

  • Genetic predisposition found for noise-induced hearing loss

  • Research Finds No Correlation between Regulatory T Cells and Survival in Glioblastoma

  • Smokers who use e-cigarettes less likely to quit, study shows

  • Adenosine receptor can activate 'off signals' for pain

  • Playing a wind instrument could help lower the risk of sleep apnea

  • Local physician recommends World Health Organization retire the term opioid substitution therapy

  • Cancer and chemobrain: Cancer diagnosis affects cognitive function

  • Forming school networks to educate 'the new mainstream'

  • Kids with ADHD must squirm to learn, study says

  •